(A) Mean fluorescence intensity (MFI) of antibody bound to nanoparticles and controls. Nano-aAPC and Micro-aAPC (cell-sized) particles were incubated with excess of monoclonal anti-mouse IgG1 (for MHC-Ig) and anti-antibody conjugated with PE for 30 minutes, and washed on a magnetic column. Fluorescent antibody bound to particles was detectable above background samples, including micro-and nanoparticles not stained with anti-IgG1 (No Ab) and particles which were not coupled to protein and stained with anti-IgG1 (Blank). Protein concentration in solution was determined by comparison to an IgG1-PE standard curve. Fluorescence is shown for anti-IgG1 and is representative of three experiments. HD -High Density. LD -Low Density. (B) Particles in solution do not interfere with antibody fluorescence. Soluble anti-IgG1 PE antibody was titrated and measured for fluorescence. Similar fluorescence emission was observed when soluble antibody was measured in the presence of blank micro-and nano-particles. (C) Washing in magnetic column was sufficient to remove free antibody. After three washes (Fraction 3), fluorescence is not detectable above background. Fluorescence of 0.63 ug/ml free antibody is provided for comparison. (D) Nanoparticle concentration was characterized by iron absorbance at 405 nm. Particle Page S3/S11 concentrations were determined by Nanoparticle Tracking Analysis. Titrations of nanoparticles were measured for absorbance and a standard curve was calculated to determine particle concentration.
The amount and density of MHC-Ig and anti-CD28 on the surface of micro-(cell-sized) and nano-aAPC. Protein was quantified as described in Supplementary Figure 1 , and particle concentration determined by counts (micro-aAPC) or Nanoparticle Tracking Analysis (nano-aAPC). High (HD) and low (LD) density particles were synthesized by varying amount of protein per particle during synthesis. Signal 1 nanoparticles were synthesized without anti-CD28. Supplementary Table 2 Ligand
T Cells Off-Rate (s -1 ) A Half-Life (s) B TCR-MHC Contacts C MHC-Ig Dimer Naive
8.9 ×10 -3 78 1 Activated 5.2 ×10 -3 112 1.7 Nanoparticle Naive (2.0 ± 0.5) × 10 -3 531 ± 149** 6.8 Activated (0.9 ± 0.2) × 10 -3 984 ± 221** 12.6 A Off-rates experiments were performed by incubating naive or activated 2C TCR transgenic T cells with APC-labeled MHC-Ig or APC-labeled nanoparticles bearing K b -SIY alone. After incubation for one hour at 4 o C, cells were washed, a Time 0 fluorescence measurement was taken, and 1B2, an anti-clonotypic antibody, was added to prevent re-binding. Fluorescence measurements were then repeated at 2-10 minute intervals. Off-rates were calculated from a one-dimensional exponential fit in GraphPad Prism.
B
Half-lives were derived from off-rates in column A. Particles bound to activated cells had a significantly longer half-life (**p<0.02 by paired t-test, where measurements were paired by experiment) than particles bound to naive cells. Three experiments were performed for each condition.
C Unbinding of individual MHC-Ig on either dimer or particle can be stochastically modeled as a Poisson (aka memoryless or exponential) Process. For a Poisson Process with rate constant r, the departure time of the nth event is characterized by a gamma distribution with shape parameter n and single-event rate parameter r:
The mean of this distribution is ‫ܧ‬ሾ‫ݐ‬ሿ ൌ ݊ ‫ݎ‬ ⁄ . If MHC-Ig dimer is assumed to make one contact with a naive T cell 1 , then r can be estimated from the off-rate of MHC-Ig on naive cells (8.9×10 -3 ). Thus, for any given condition, ‫ܧ‬ሾ‫ݐ‬ሿ is derived from the half-life of MHC-Ig dimer or particle on naive or active cells (‫ݐ‬ଵ ଶ ൗ ሻ, and r is assumed constant. The number of TCR-MHC contacts is estimated as n:
The true number of contacts is likely to be higher than this estimate, as MHC-Ig are likely to make more than one contact with naive cells.
